Sun, Dec 21, 2014, 2:52 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • thirdmeinvestor thirdmeinvestor May 25, 2010 4:40 PM Flag

    75% SVR for ADVANCE study!!!!

    Q, thank you. I will work on the estimates for the other two trials.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Right on the nose Thirdmind (1% doesn't count!).

      Whoever it was a few days ago in another thread who said that Phase 3 results are "always worse than Phase 2" must be doing some reassessment at the moment.

      • 1 Reply to DrvMan247
      • It was the Bozo below:

        "Re: SVR debate is missing the point! 22-May-10 11:48 pm juliuservin...Male


        Does anyone on this board know anything about the treatment of HCV?

        I am going to say not. First off, the days of getting rid of interferon are a long, long way off. You might beat down the virus with 2 antivirals, but you will need both interferon and rbv to hold an SVR. Second, when a compound goes into Phase 3, the chances of the results looking better than a Phase 2 are slim to none. Third, VX950 will be a good thing for the hepatitis C patients, but it will also come with a cost (rash, dosing of Q8 / comliance issues, and cost). Rating :
        (No ratings)Rate it:"




        --------------------------------------------------------------------------------

        View Messages

 
VRTX
118.90+1.16(+0.99%)Dec 19 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Aegerion Pharmaceuticals, Inc.
NASDAQFri, Dec 19, 2014 4:00 PM EST
ImmunoGen, Inc.
NASDAQFri, Dec 19, 2014 4:00 PM EST
Linn Co, LLC
NASDAQFri, Dec 19, 2014 3:59 PM EST